Spanish government appeals against new law on generics in Galicia that is set to save €93m a yearBMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d1036 (Published 14 February 2011) Cite this as: BMJ 2011;342:d1036
- Aser García Rada
The Spanish government and a drug industry group have brought legal proceedings against the regional government in Galicia, which in December approved a law to limit prescribing of branded drugs. The new law could save the region €93m (£78m; $125m) each year, the regional government says.
The new law in the autonomous region of Galicia, which has a population of around 2.8 million, has been in force since January. It restricts the prescription of 427 branded drugs that contain 34 active ingredients, forcing doctors to prescribe the generic versions instead.
Doctors in Galicia write 250 000 prescriptions every day, about 40 000 of which are for drugs included in the banned list. The head of the regional health department in Galicia, Pilar Farjas, of the conservative Popular …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial